The effect of recombinant human osteogenic protein-1 on allograft incorporation

Journal of Bone and Joint Surgery - Series B

Volumn 87, Issue 9, 2005, Pages 1292-1297

  Lietman, S A ^a   Inoue, N ^b   Rafiee, B ^b   Deitz, L W ^b   Chao, E Y S ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE ALLOGRAFT; BONE DEFECT; CALLUS; CONTROLLED STUDY; DOG; HEALING; HISTOLOGY; MORPHOMETRICS; NONHUMAN; PERIOSTEUM; PRIORITY JOURNAL; RIGIDITY; TORQUE; X RAY ANALYSIS;

ANIMALS; BIOMECHANICS; BONE TRANSPLANTATION; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DOGS; DRUG DELIVERY SYSTEMS; OSSEOINTEGRATION; PROTEINS; RECOMBINANT PROTEINS; WEIGHT-BEARING;

EID: 25844473491     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.87B9.15955     Document Type: Article

References (38)

1. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
2. Bostrom M, Lane JM, Tomin E, et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 1996;327:272-82.
3. Bostrom MP, Camacho NP. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 1998;355(Suppl):274-82.
4. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg [Br] 1999; 81-B:710-18.
5. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 1999;22:669-71.
6. Gordh M, Alberius P, Johnell O, Lindberg L, Linde A. Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting. Plast Reconstr Surg 1999; 103:1909-18.
7. Reddi AH. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop 1998;355(Suppl):66-72.
8. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2: biology and applications. Clin Orthop 1996;324:39-46.
9. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg [Am] 2001;83-A:803-16.
10. Kawakami T, Kawai T, Takei N, et al. Evaluation of heterotopic bone formation induced by squalane and bone morphogenetic protein composite. Clin Orthop 1997; 337:261-6.
11. Zabka AG, Pluhar GE, Edwards RB 3rd, et al. Histomorphometric description of allograft bone remodelling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. J Orthop Res 2001;19:318-27.
12. Gao T, Lindholm TS, Marttinen A, Urist MR. Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics. Int Orthop 1996;20:321-5.
13. Ike M, Urist MR. Recycled dentin root matrix for a carrier of recombinant human bone morphogenetic protein. J Oral Implantol 1998;24:124-32.
14. Kawamura M, Urist MR. Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix noncollagenous proteins. Clin Orthop 1988;236:240-8.
15. Kubler NR, Reuther JF, Faller G, et al. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillof Surg 1998;27: 305-9.
16. Niederwanger M, Urist MR. Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogenic bone grafts. J Oral Implantol 1996;22:210-15.
17. Urist MR, Lietz A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984;187:277-80.
18. Urist MR, Nilsson O, Rasmussen J, et al. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop 1987;214:295-304.
19. Cullinane DM, Lietman SA, Inoue N, Deitz LW, Chao EY. The effect of recombinant human osteogenic protein-1 (bone morphogenetic protein-7) impregnation on allografts in a canine intercalary bone defect. J Orthop Res 2002;20:1240-5.
20. Andrews W, Damjanov I, Berends J, et al. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 1994;71:243-51.
21. Fischgrund JS, James SB, Chabot MC, et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 1997;10:467-72.
22. Itoh K, Udagawa N, Katagiri T, et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001;142:3656-62.
23. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995;10:1681-90.
24. Koide M, Murase Y, Yamato K, et al. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 1999;259:97-102.
25. Tagil M, Jeppsson C, Aspenberg P. Bone graft incorporation: effects of osteogenic protein-1 and impaction. Clin Orthop 2000;371:240-5.
26. Lietman SA, Yanagishita M, Sampath TK, Reddi AH. Stimulation of proteoglycan synthesis in explants of porcine articular cartilage by recombinant osteogenic protein-1 (bone morphogenetic protein-7). J Bone Joint Surg [Am] 1997;79-A:1132-7.
27. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop 1996;324:86-97.
28. Lietman SA, Tomford WW, Gebhardt MC, Springfield DS, Mankin HJ. Complications of irradiated allografts in orthopaedic tumor surgery. Clin Orthop 2000;375: 214-17.
29. Sorensen MS, Bretlau P, Jorgensen MB. Bone repair in the otic capsule of the rabbit. Acta Otolaryngol 1992;112:968-75.
30. Keller TS, Moeljanto E, Main JA, Spengler DM. Distribution and orientation of bone in the human lumbar vertebral centrum. J Spinal Disord 1992;5:60-74.
31. Pluhar GE, Manley PA, Heiner JP Jr RV, Seeherman HJ, Markel MD. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res 2001;19:308-17.
32. Maliakal JC, Asahina I, Hauschka PV, Sampath TK. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors 1994;11: 227-34.
33. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999;112:4557-68.
34. Muthukumaran N, Ma S, Reddi AH. Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Coll Relat Res 1988;8:433-41.
35. Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA 1972;69:1601-5.
36. Sampath TK, DeSimone DP, Reddi AH. Extracellular bone matrix-derived growth factor. Exp Cell Res 1982;142:460-4.
37. Sampath TK, Nathanson MA, Reddi AH. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci USA 1984;81:3419-23.
38. Love DA, Lietman SA. The effect of osteogenic protein-1 dosing regimen on ectopic bone formation. Clin Orthop 2004;423:264-7.